Correction: CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608645/
https://www.ncbi.nlm.nih.gov/pubmed/36283738
http://dx.doi.org/10.1136/jitc-2021-004022corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9608645/
https://www.ncbi.nlm.nih.gov/pubmed/36283738
http://dx.doi.org/10.1136/jitc-2021-004022corr1

Ejemplares similares